Curenetics

Curenetics is a medical technology company developing AI-powered tools to predict cancer patient responses to immunotherapy before treatment begins.

Its platform integrates multi-omic genomic data, imaging profiles and clinical information to identify biomarkers of treatment efficacy and toxicity. The company also offers AI-driven clinical trial matching for cancer patients.

Founded by practicing NHS oncologist Dr Sola Adeleke, Curenetics collaborates with the University of Pittsburgh, Queen Mary University of London and multiple NHS trusts.